HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Schirrmacher, V. Articles by Pross, H. Search for Related Content PubMed Articles by Schirrmacher, V. Articles by Pross, H.

Cytotoxic Immune Cells with Specificity for Defined Soluble Antigens

V. Interaction of Antibody with the Cytotoxic Effector Cells in Immune or Non-Immune Mouse Spleen Cells¹

Department of Tumorbiology, Karolinska Institute, Stockholm, Sweden

Abstract

Antigen-coated target cells were specifically lysed (a) by spleen cells from mice that had been immunized against the antigen presented in a soluble form and (b) by non-immune mouse spleen cells in the presence of specific antibodies. In the immune cell cytotoxic system, which consists of antibody-producing cells (APC) and cytotoxic effector cells (CEC), limiting dilution assays showed that the APC were diluted out before the CEC so that the amount of antibody being produced in vitro was limiting the cytotoxicity. In the presence of optimal concentrations of antibody, CEC from immune and non-immune cells were equally effective, regardless of whether the immune cells and the antibody were of the same or of different specificity.

In vitro cytotoxicity in the immune spleen cell system started after a lag period of about 3 hr and was depressed to about 50% after the cells had been treated with trypsin. The cytotoxic activity of non-immune spleen cells in the presence of antibody started without a lag period and was not affected by trypsin treatment of the cells.

Both the immune and the non-immune cell cytotoxic system were blocked by unrelated antigen-antibody complexes. Antibody-complexed target cells were much more potent inhibitors than were soluble complexes. Small numbers of target cells heavily coated with antibody were as efficient in blocking as were larger numbers of target cells lightly coated with antibody. The inhibition by antibodycomplexed antigen-coated target cells was neutralized by the addition of soluble antigen. This "unblocking" was thought to be due to a competition between soluble and insoluble antigen for antibody and the creation of non-inhibitory soluble complexes. The relevance of these findings for anti-tumor immune systems is discussed.

Footnotes

¹ This work was conducted under Contract No. NIH-NOI-CB-33859, National Institutes of Health, United States Public Health Service. It was further supported by the Swedish Cancer Society, the Karolinska Institute, the Deutsche Forschungsgemeinschaft, the Statens Laegevidenskabelige Forskningsrad, Denmark, and the Medical Research Council of Canada.

² Address correspondence to: V. Schirrmacher, The London Hospital Medical College, Tissue Immunology, University of London, London E1 2AD, England.

³ Present address: Immunobiology Laboratory, Statens Seruminstitute, DK-2300 Copenhagen, Denmark.

⁴ Fellow of the Medical Research Council of Canada.